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3Abstract 
Hypoparathyroidism is genetically heterogeneous and characterized by low plasma calcium 
and parathyroid hormone (PTH) concentrations. X-linked hypoparathyroidism (XLHPT) in 
two American families, is associated with interstitial deletion-insertions involving deletions of 
chromosome Xq27.1 downstream of SOX3 and insertions of predominantly non-coding DNA 
from chromosome 2p25.3.  These could result in loss, gain, or movement of regulatory 
elements, which include ultraconserved element uc482, that could alter SOX3 expression,. To 
investigate this, we analysed SOX3 expression in EBV-transformed lymphoblastoid cells from 
3 affected males, 3 unaffected males, and 4 carrier females from one XLHPT family.  SOX3 
expression was similar in all individuals, indicating that the spatiotemporal effect of the 
interstitial deletion-insertion on SOX3 expression postulated to occur in developing 
parathyroids did not manifest in lymphoblastoids.  Expression of SNTG2, which is duplicated 
and inserted into the X chromosome, and ATP11C, which is moved telomerically, were also 
similarly expressed in all individuals.  Investigation of male hemizygous (Sox3-/Y and uc482-/Y) 
and female heterozygous (Sox3+/- and uc482+/-) knock-out mice, together with wild-type 
littermates (male Sox3+/Y and uc482+/Y, and female Sox3+/+ and uc482+/+), revealed Sox3-/Y, 
Sox3+/-, uc482-/Y, and uc482+/- mice to have normal plasma biochemistry, compared to their 
respective wild-type littermates.  When challenged with a low calcium diet, all mice had 
hypocalcaemia, and elevated plasma PTH concentrations and alkaline phosphatase activities, 
and Sox3-/Y, Sox3+/-, uc482-/Y, and uc482+/- mice had similar plasma biochemistry, compared to 
wild-type littermates.  Thus, these results indicate that absence of Sox3 or uc482 does not cause 
hypoparathyroidism, and that XLHPT likely reflects a more complex mechanism. 
(250 words/max 250)
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41. Introduction
Heritable hypoparathyroidism (HPT) is a genetically heterogeneous disease, characterized 
biochemically by hypocalcaemia, hyperphosphatemia, low plasma parathyroid hormone (PTH) 
concentrations and inappropriately normal or high urinary calcium excretion (1).  Genetic 
abnormalities causing HPT may lead to complex congenital syndromes or to an isolated 
endocrinopathy, for which autosomal dominant, autosomal recessive and X-linked modes of 
inheritance have been described (OMIM #146200 and %307700) (2).  These genetic 
abnormalities may result in defects in PTH itself, parathyroid gland development, or 
parathyroid gland function. For example, mutations in PTH cause a lack of functional PTH 
protein (3), mutations in the parathyroid-specific transcription factor glial cells missing B 
(GCMB) result in defective parathyroid gland development (4,5), and gain-of-function 
mutations in the calcium sensing receptor (CaSR) may suppress parathyroid gland function in 
association with hypocalcaemia (6).
X-linked HPT (XLHPT, OMIM %307700) was first reported in 1960 (7) in a large kindred 
from Missouri (MO), USA and subsequently in a related family also from MO (8-10), and 
more recently in a third, unrelated family from Illinois (IL), USA (11). Both families from MO 
and the family from IL had interstitial deletion-insertions involving deletion of a non-coding 
region on chromosome Xq27.1 between sex-determining region Y (SRY)-box 3 (SOX3) and 
adenosine triphosphatase 11C (ATP11C), and an insertion of a larger section emanating from 
chromosome 2p25.3 (8,11) (Figure 1A).  In the MO kindred, this consisted of a ~25kb deletion 
of non-coding DNA from Xq27.1 ~67kb downstream of SOX3 and an inverted insertion of 
~340kb containing exons 2-16 of syntrophin gamma 2 (SNTG2) from 2p25.3 (8) (Figure 1A). 
In the IL family, ~1.5kb was deleted from Xq27.1 ~80kb downstream of SOX3 and ~47kb of 
non-coding DNA was inserted from 2p25.3, which differed from the inserted DNA in the MO 
kindred (11) (Figure 1A).  Although the 340kb insertion in the MO kindred contained 15 exons 
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5of SNTG2, no open reading frames were present (8), and the 47kb insertion in the IL family did 
not contain coding DNA.  Similarly, neither of the X chromosome deletions removed coding 
DNA. We therefore hypothesized that these rearrangements may alter the function of a 
regulatory element or nearby gene, that affects SOX3 expression, which has been demonstrated 
in developing mouse parathyroids between embryonic day (E)10.5 and E15.5 (8).  SOX3 
expression was reported to be altered by a large 774kb insertion downstream of SOX3 in 
patients with XX male sex reversal, demonstrating that SOX3 expression may be susceptible to 
position effects, similar to those reported for SOX9 and SRY (12,13), although SOX3 coding 
mutations have not been identified in male patients with HPT (14).
Thus, in the XLHPT families there are three possible mechanisms that could result in such 
alterations in SOX3 expression (Figure 1B).  Firstly, deletions of X chromosome sequences 
may result in loss of a repressor or enhancer of SOX3 expression.  Secondly, insertions of 
chromosome 2 sequences may result in insertion of DNA that may repress or enhance SOX3 
expression.  Thirdly, deletion-insertions, that result in a net gain of DNA on the X 
chromosome, may move a repressor or enhancer of SOX3 expression further away from SOX3, 
thereby altering its effect on SOX3 expression, i.e. a position effect (Figure 1B).  Gene 
enhancers and repressors are often evolutionarily conserved, and >60% of ultraconserved (uc) 
non-coding elements that are conserved in human through to Takifugu rubripes (puffer fish), 
may act as positive enhancers (15).  One such element, designated uc482 (or highly conserved 
non-coding element (HCNE) 8), is located ~400kb downstream of SOX3 and was reported to 
be a likely enhancer of Sox3 expression in Danio rerio (zebrafish) (16).  Furthermore, uc482 is 
moved further away from SOX3 by both of the deletion-insertions causing XLHPT (Figure 
1B).
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6To explore the possible roles of SOX3 and uc482 in HPT, we undertook studies to determine 
the effects of the interstitial deletion-insertion on SOX3 expression in patients with XLHPT and 
in knock-out mice lacking alleles of Sox3 and uc482.
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72. Materials and methods
2.1. Human studies
Venous blood samples were collected after informed consent from individuals and following 
protocols approved by local and national ethics committees (Multi-centre Research Ethics 
Committee (London, UK; MREC 02/2/93) and the Human Research Protections Office, 
Washington University School of Medicine, St. Louis, MO, USA).
2.2. DNA sequence analysis
DNA was extracted from leukocytes using the Gentra Puregene blood kit (Qiagen, Manchester, 
UK) and standard protocols.  PCR amplification of DNA across the deletion-insertion 
boundaries was carried out using primers previously described (8), and Sanger DNA sequence 
analysis was performed using the BigDye Terminator v3.1 Cycle Sequencing Kit (Life 
Technologies, Inchinnan, UK) and an ABI automated capillary sequencer (Applied 
Biosystems, Warrington, UK), as described (4,8).  
2.3. Quantitative Real-Time PCR (qRT-PCR)
Lymphocytes were Epstein-Barr virus (EBV)-transformed to generate a lymphoblastoid cell 
line as previously described (3), and mRNA extracted using the Oligotex mRNA mini kit 
(Qiagen) and standard protocols.  cDNA was generated using Quantiscript reverse transcriptase 
(Qiagen), and quantitative reverse transcriptase (qRT)-PCRs performed using the QuantiTect 
SYBR Green PCR kit (Qiagen) in quadruplicate for each individual, and SOX3, SNTG2, 
ATP11C, and GAPDH specific primers, using a Rotorgene 5 (Qiagen), as described (17).  
Expression of genes was normalized to GAPDH expression, and analyzed by the comparative 
ΔΔCT method (18).
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82.4. Mouse studies
All animal studies were approved by the University of Oxford Ethical Review Committee and 
were licensed (project license numbers PPL 30/2241, PPL 30/2739 and PPL 30/3251) under 
the Animals (Scientific Procedures) Act 1986, issued by the UK Government Home Office. 
Sox3 knock-out mice were maintained on the MF1 outbred background (19) and uc482 knock-
out mice were maintained on the C57Bl/6 background (20). Mice were genotyped using DNA 
extracted from ear biopsies followed by PCR assay.  PCR primers for: Sox3 genotyping were: 
WT F: 5’-TCGGGTGGTGGGGAAGGGGTTAT-3’, WT R: 5’-GTGGGGTGTGCGGCTCAGGTAG-
3’, KO F: 5’-CACGGCGAGCCTGTCAATCACGAG-3’, KO R: 5’-
TTGATGCCGTTCTTTTGCTTGTCG-3’; and for uc482 genotyping were: For: 5’-
GGAAATGAGGCCGAGTCAAG-3’; WT R: 5’-TACGAAGACATGTACCTGTGCG-3’; KO R: 5’-
TGGACTTGTCAGCTTCTTCCAA-3’. After weaning at age 21 days, mice were fed either a 
synthetic control diet (Dyets Inc., Bethlehem, PA, USA) containing 0.95% calcium and 
4.50iU/g vitamin D3, or a synthetic low calcium diet containing 0.001% calcium and 0.0iU/g 
vitamin D3 (Dyets Inc.), as previously described (21).  The low calcium/no vitamin D3 diet has 
previously been shown to unmask defects in the ability of the parathyroid glands to respond to 
deficiencies in dietary calcium, which may not be evident when calcium is abundant (21). Food 
and water were allowed ad libitum.  Mice were euthanized and blood collected from the 
jugular vein for plasma analysis using an AU400 clinical chemistry analyser (Olympus, 
Southend-On-Sea, UK), and plasma calcium was corrected for albumin (Corr. Ca) using the 
formula: Corr. Ca = Ca (mmol/l)-((Alb(g/l)-30)x0.017), as described (22).  PTH concentrations 
were measured using an enzyme-linked immunosorbant assay (ELISA) for mouse intact PTH 
(Immutopics), as described (22).  
2.5. Histological studies
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9To study parathyroids of the knock-out mice, the trachea, thyroid, and parathyroids were 
dissected en bloc and fixed for 24 hours in 10% neutral buffered formalin.  Paraffin sections 
(6µm thickness) were dewaxed and stained with hematoxylin and eosin (H&E) using standard 
techniques. H&E stained sections were viewed using an Eclipse E400 light microscope (Nikon, 
Kingston-Upon-Thames, UK) and images acquired using NIS-elements BR2.30 imaging 
software (Nikon).  An estimation of parathyroid gland size was performed by measuring the 
largest cross-sectional area of the parathyroid gland in serial sections from each mouse, as 
described (21,23), and corrected for body weight. 
2.6. Statistical analyses
For human qRT-PCR analyses, data was analyzed using one-way ANOVA, and all data are 
represented as mean ±SD fold change relative to unaffected males. For animal studies, data 
was analyzed using unpaired Student’s t-test. All data are represented as mean ±SD, and for 
plasma biochemical results, significances are reported after Bonferroni correction for multiple 
comparisons. 
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3. Results
3.1. Expression of SOX3, ATP11C and SNTG2 in patients with XLHPT
PCR analysis using primers, previously described (8), that spanned the telomeric breakpoint, 
was used to confirm the presence or absence of the X chromosome deletion-insertion in 3 
affected males, 4 carrier females, and 3 unaffected related males from the MO kindred (Figure 
2A).  Thus, individuals II.5, II.6 and III.1, who are unaffected males with normocalcemia, were 
confirmed to have only the wild-type (normal) allele; individuals IV.1, IV.2 and IV.3, who are 
affected males with hypocalcemia due to XLHPT, were confirmed to have only the mutant 
allele; and individuals II.2, II.3, II.4 and III.2, who are carrier females with normocalcemia, 
were confirmed to be heterozygous in having wild-type and mutant alleles (Figure 2A).  
Parathyroid glands from XLHPT patients (7), and normal individuals were not available to 
study the expression of SOX3 and ATP11C, which flank the interstitial deletion-insertion 
involving chromosomes Xq27.1 and 2p25.3, and the inserted region of SNTG2 in the XLHPT 
MO kindred (Figure 1).  Lymphoblastoid cell mRNA was therefore used to undertake qRT-
PCR analysis of SOX3, ATP11C and SNTG2 expression (Figure 2B).  SOX3 expression 
(mean±SD) was similar in affected males (1.21±1.53-fold) and carrier females (0.85±0.98-
fold), when compared to unaffected males (1.00±0.68-fold; p>0.8) (Figure 2B).  qRT-PCR 
analyses of ATP11C, which is located downstream of the deletion-insertion, and SNTG2, of 
which exons 2-16 are inserted from chromosome 2p25.3, revealed no significant differences in 
expression of ATP11C or SNTG2 between affected males (0.80±0.32-fold and 1.18±0.92-fold, 
respectively) or carrier females (0.91±0.20-fold and 1.11±0.79-fold, respectively), when 
compared to unaffected males (1.00±0.78-fold and 1.00±0.65-fold; p>0.8) (Figure 2B).  These 
results indicated that specific spatiotemporal effects of the XLHPT-associated interstitial 
deletion-insertions on expression of SOX3 or other genes, ATP11C and SNTG2, postulated to 
occur in the developing parathyroids, were not occurring in lymphoblastoid cells, which are not 
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representative of parathyroid cells.  We therefore studied mouse knock-out models deleted for 
Sox3 and uc482.
3.2. Mice deleted for Sox3 have normal plasma calcium and PTH concentrations
Mice were genotyped (Figure 3A), and wild-type (Sox3+/Y) and hemizygous (Sox3-/Y) male 
adult mice, and wild-type (Sox3+/+) and heterozygous (Sox3+/-) female adult mice were found to 
have normal body weights and plasma biochemistry at ages 6 and 28 weeks (Table 1).  Thus, 
corrected calcium concentrations in plasma were similar in: Sox3+/Y mice compared to Sox3-/Y 
mice (3.08±0.11mmol/l vs 3.05±0.15mmol/l at 6 weeks, and 2.83±0.19mmol/l vs 
2.79±0.12mmol/l at 28 weeks, n=10-21); and in Sox3+/+ mice compared to Sox3+/- mice 
(3.02±0.08mmol/l vs 3.06±0.10mmol/l at 6 weeks, and 2.65±0.12mmol/l vs 2.73±0.11mmol/l 
at 28 weeks, n=9-25).  Plasma PTH concentrations were also similar in: Sox3+/Y and Sox3-/Y 
mice (11.8±7.6pmol/l vs 12.8±10.4pmol/l at 6 weeks, and 41.8±31.4pmol/l vs 35.9±34.1pmol/l 
at 28 weeks, n=14-22); and in Sox3+/+ and Sox3+/- mice (15.3±11.8pmol/l vs 9.9±10.6pmol/l at 
6 weeks, and 35.6±23.8pmol/l vs 24.8±19.1pmol/l at 28 weeks, n=12-24) (Table 1).  In 
addition, the plasma phosphate, urea, creatinine and albumin concentrations, and alkaline 
phosphatase activity were similar in wild-type and mutant Sox3 mice at 6 and 28 weeks of age 
(Table 1).
The standard control mouse chow contains 0.95% calcium and 4.5iU/g vitamin D3, which 
represent levels that are ~150-fold and ~30-fold higher, respectively, than those recommended 
for daily intake in humans (21).  Furthermore, these high dietary contents of calcium and 
vitamin D have been reported to mask hypocalcaemia in mice with a different cause of HPT 
(21).  We therefore challenged Sox3+/Y, Sox3-/Y, Sox3+/+, and Sox3+/- mice with a diet low in 
calcium (0.001%) and lacking in vitamin D3 (low diet) from weaning until 60 days old.  Wild-
type male and female mice on the low diet had significantly lower plasma corrected calcium 
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concentrations than those on the control diet (mean±SD) (low diet versus control diet for 
Sox3+/Y = 1.96±0.24mmol/l vs 3.08±0.11mmol/l, p<0.001; and Sox3+/+ = 2.01±0.26mmol/l vs 
3.02±0.08mmol/l, p<0.001, n=16-25) (Figure 3B).  These lower plasma corrected calcium 
concentrations, were not due to lower plasma albumin concentrations when on the low diets, as 
these plasma albumin concentrations were similar (Sox3+/+ = 32.70 ±0.35g/L, Sox3+/- = 32.58 
±0.24g/L, Sox3+/Y = 31.50 ±0.34g/L and Sox3-/Y = 32.40 ±0.40g/L), on low diet to those 
observed in mice on the control diet (Table 1).  This hypocalcaemia was associated with 
significant increases in plasma PTH concentrations (Sox3+/Y = 150.1±46.3pmol/l vs 
11.8±7.6pmol/l, p<0.001; and Sox3+/+ = 157.8±47.6pmol/l vs 15.3±11.8pmol/l, p<0.001, n=15-
24) (Figure 3C) and alkaline phosphatase (ALP) activities (Sox3+/Y = 668.1±161.9U/l vs 
258.7±47.2U/l, p<0.001; Sox3+/+ = 820.8±234.4U/l vs 296.5±58.4U/l, p<0.001, n=16-25) 
(Figure 3D).  Wild-type mice on the low diet, compared to those on the control diet, also had 
significantly lower plasma urea concentrations (Sox3+/Y = 5.98±0.91mmol/l vs 
7.85±1.24mmol/l, p<0.001; and Sox3+/+ = 5.69±0.99mmol/l vs 6.90±1.13mmol/l, p=0.042, 
n=18-25) (Figure 3E) and creatinine concentrations (Sox3+/Y = 14.3±0.4µmol/l vs 
17.3±0.8µmol/l, p<0.001; and Sox3+/+ = 14.9±1.11µmol/l vs 17.7±0.9µmol/l, p<0.001, n=17-
23) (Figure 3F). 
Similar to wild-type mice, mutant male (Sox3-/Y) and heterozygote female (Sox3+/-) mice on the 
low diet also had significantly lower plasma corrected calcium concentrations than those on the 
control diet (Sox3-/Y = 1.93±0.20mmol/l vs 3.05±0.15mmol/l, p<0.001; and Sox3+/- = 
1.91±0.14mmol/l vs 3.06±0.10mmol/l, p<0.001, n=13-24) (Figure 3B).  This was associated 
with significantly higher plasma: PTH concentrations (Sox3-/Y = 162.6±37.6pmol/l vs 
12.8±10.4pmol/l, p<0.001; and Sox3+/- = 187.5±28.6pmol/l vs 9.9±10.6pmol/l, p<0.001, n=13-
21) (Figure 3C); and ALP activities (Sox3-/Y = 700.3±183.2U/l vs 270.2±49.4U/l, p<0.001; 
Sox3+/- = 906.4±217.2U/l vs 282.4±48.4U/l, p<0.001, n=12-22) (Figure 3D).  Sox3-/Y and 
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Sox3+/- mice on the low diet also had significantly lower plasma: urea concentrations (Sox3-/Y= 
6.06±0.92mmol/l vs 7.83±0.87mmol/l, p<0.001; and Sox3+/- = 5.88±0.92mmol/l vs 7.10±0.74 
mmol/l, p<0.018, n=13-25) (Figure 3E); and creatinine concentrations (Sox3-/Y = 
13.2±1.3µmol/l vs 16.8±1.4µmol/l, p<0.001; and Sox3+/- = 15.3±1.3µmol/l vs 17.7±1.6µmol/l, 
p<0.002, n=12-23) (Figure 3F).  The plasma corrected calcium and PTH concentrations in 
Sox3-/Y and Sox3+/- mice on the low diet were not statistically different to the wild-type mice on 
the low diet, indicating that Sox3-/Y and Sox3+/- mice have normal parathyroid function (Figure 
3B, C).  Plasma ALP activities and urea and creatinine concentrations were also similar in 
wild-type mice compared to Sox3-/Y and Sox3+/- mice on the low calcium diet (Figure 3D-F).
Histological analysis of parathyroid gland size from wild-type and mutant Sox3 mice revealed 
that parathyroid gland areas in Sox3+/Y and Sox3-/Y mice were significantly greater, in keeping 
with diet-induced secondary hyperparathyroidism, in mice on the low diet, when compared to 
the control diet (Sox3+/Y = 3885±1012µm2/g vs 1824±656µm2/g, p=0.007; and Sox3-/Y = 
4672±1914µm2/g vs 2539±684µm2/g, p=0.040, n=4); however, there was no difference 
between Sox3+/Y and Sox3-/Y mice on each diet (normal diet p=0.091; low diet p=0.247) (Figure 
3G, H).  Parathyroid gland sizes in Sox3+/+ and Sox3+/- mice were similar on the low diet 
compared to the control diet (Sox3+/+ = 4065±1178µm2/g vs 2775±1244µm2/g, p=0.091; and 
Sox3+/- = 4542±1664µm2/g vs 2684±1010µm2/g, p=0.052, n=4), and there was no difference 
between Sox3+/+ and Sox3+/- mice on each diet (normal diet p=0.457; low diet p=0.328) (Figure 
3G).  Thus, Sox3-/Y and Sox3+/- mice appear to have normal parathyroid function and normal 
responses to hypocalcaemia, and loss of Sox3 does not result in smaller parathyroids or HPT.
3.3. Mice deleted for ultraconserved element uc482 have normal plasma calcium and 
PTH concentrations
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Mice were genotyped (Figure 4A) and wild-type (uc482+/Y) and hemizygous (uc482-/Y) male 
adult mice, and wild-type (uc482+/+) and heterozygous (uc482+/-) female adult mice were found 
to have normal plasma biochemistry at the ages of 8 weeks and 28 weeks (Table 2).  Thus, 
plasma corrected calcium concentrations were similar in: uc482+/Y mice compared to uc482-/Y 
mice (2.95±0.08mmol/l vs 2.98±0.10mmol/l at 8 weeks, and 2.76±0.08mmol/l vs 
2.83±0.13mmol/l at 28 weeks, n=10-24); and in uc482+/+ mice compared to uc482+/- mice 
(2.80±0.07mmol/l vs 2.84±0.12mmol/l at 8 weeks, and 2.70±0.05mmol/l vs 2.72±0.12mmol/l 
at 28 weeks, n=7-42) (Table 2).  Plasma PTH concentrations were also similar in: uc482+/Y and 
uc482-/Y mice (12.9±9.3pmol/l vs 12.1±9.0pmol/l at 8 weeks, and 19.9±16.7pmol/l vs 
26.7±15.3pmol/l at 28 weeks, n=14-20); and in uc482+/+ and uc482+/- mice (11.1±10.4pmol/l vs 
23.5±24.3pmol/l at 8 weeks, and 18.4±20.2pmol/l vs 13.6±12.0pmol/l at 28 weeks, n=9-19) 
(Table 2).   In addition, the plasma phosphate, urea, creatinine and albumin concentrations, and 
alkaline phosphatase activities were similar in wild-type and mutant uc482 mice at 8 weeks 
and 28 weeks of age (Table 2). 
When challenged with the low diet for 60 days, plasma corrected calcium concentrations were 
significantly lower in: male wild-type (uc482+/Y) and mutant hemizygous (uc482-/Y) mice 
(uc482+/Y = 2.01±0.17mmol/l vs 2.95±0.08mmol/l, p<0.0001; and uc482-/Y = 1.90±0.27 vs 
2.98±0.10mmol/l, p<0.0001, n=10-24); and in female wild-type (uc482+/+) and heterozygous 
(uc482+/-) mice (uc482+/+ = 1.92±0.11mmol/l vs 2.80±0.07mmol/l, p<0.0001; and uc482+/- = 
1.93±0.17mmol/l vs 2.84±0.12mmol/l, p<0.0001, n=14-42) (Figure 4B).  These lower plasma 
corrected calcium concentrations, were not due to lower plasma albumin concentrations when 
on the low diets, as these plasma albumin concentrations were similar (uc482+/+ = 30.44 ±0.34 
g/L, uc482+/- = 30.73 ±0.26 g/L, uc482+/Y = 30.63 ±0.38 g/L and uc482-/Y = 30.41 ±0.70 g/L), 
on low diet to those observed in mice on the control diet (Table 2).  This was associated with 
significantly higher plasma PTH concentrations in: uc482+/Y and uc482-/Y mice (uc482+/Y = 
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194.6±48.2pmol/l vs 12.9±9.3pmol/l, p<0.0001; and uc482-/Y = 194.0±36.3pmol/l vs 
12.1±9.0pmol/l, p<0.0001, n=10-20); and in uc482+/+ and uc482+/- mice (uc482+/+ = 
211.3±26.4pmol/l vs 11.1±10.4pmol/l, p<0.0.0001; and uc482+/- = 226.3±54.4pmol/l vs 
23.5±24.3pmol/l, p<0.0001, n=9-19) (Figure 4C).  Plasma ALP activities were also 
significantly higher in: uc482+/Y and uc482-/Y mice (uc482+/Y = 1062.7±233.1U/l vs 
280.7±53.9U/l, p<0.0001; and uc482-/Y = 1123.0±125.4U/l vs 279.8±36.8U/l, p<0.0001, n=17-
29); and in uc482+/+ and uc482+/- mice (uc482+/+ = 1189.9±211.0U/l vs 286.8±41.1U/l, 
p<0.0001; and uc482+/- = 1133.7±346.5U/l vs 293.8±40.1U/l, p<0.0001, n=13-40) (Figure 4D).  
The plasma corrected calcium and PTH concentrations, and plasma ALP activities in uc482-/Y 
and uc482+/- mice on the low diet were similar to those of the uc482+/Y and uc482+/+ mice, 
respectively, on the control diet, indicating that uc482-/Y and uc482+/- mice have normal 
parathyroid function (Figure 4B-D).  There were no differences in plasma urea or creatinine 
concentrations between uc482+/Y, uc482+/+, uc482-/Y or uc482+/- mice on the low diet compared 
to the control diet (Figure 4E-F).
Histological analysis of parathyroid gland size from wild-type and mutant uc482 mice revealed 
that parathyroid gland areas in all genotypes were significantly larger, in keeping with diet-
induced secondary hyperparathyroidism, in mice on the low diet compared to the control diet 
(uc482+/Y = 7697±1596µm2/g vs 3545±824µm2/g, p=0.002; uc482-/Y = 7887±1016µm2/g vs 
3797±802µm2/g, p<0.001; uc482+/+ = 7525±1780µm2/g vs 4220±1348µm2/g, p=0.013; and 
uc482+/- = 7693±276µm2/g vs 5123±782µm2/g, p=0.004, n=4) (Figure 4G, H).  There were no 
differences between uc482+/Y and uc482-/Y mice, or between uc482+/+ and uc482+/- mice, either 
on the control diet, or the low diet (uc482+/Y vs uc482-/Y control diet p=0.338 and low diet 
p=0.424; and uc482+/+ vs uc482+/- control diet p=0.145 and low diet p=0.432).  Thus, uc482-/Y 
and uc482+/- mice appear to have normal parathyroid gland function and normal responses to 
hypocalcaemia, and loss of uc482 does not result in smaller parathyroids or HPT.
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4. Discussion
The molecular and cellular effects of the interstitial deletion-insertion involving chromosomes 
Xq27.1 and 2p25.3 in 2 families with XLHPT and their effects on SOX3 expression in the 
etiology of HPT remain to be elucidated (Figure 1).  Elucidation of the mechanism(s) may also 
have relevance to other disorders, as interstitial deletion-insertions involving deletions at the 
same locus on Xq27.1, but insertions from other autosomes, have been described in other 
diseases (7,24-26) (Figure 5).  For example, three families with X-linked congenital 
generalized hypertrichosis (CGH) have been reported to have deletion-insertions comprising: a 
Chinese family with a ~1.3kb Xq27.1 deletion and a ~125.5kb 5q35.3 insertion containing 
intronic sequence from within collagen type 23, alpha 1 (COL23A1); a Mexican family with a 
7bp deletion and a ~300kb 4q31.22-31.23 inverted insertion containing protein arginine 
methyltransferase 10 (PRMT10), transmembrane protein 184C (TMEM184C), and parts of Rho 
GTPase activating protein 10 (ARHGAP10) and endothelin receptor type A (EDNRA); and 
another Mexican family with a 2bp Xq27.1 deletion and a ~389kb 6p21.2 insertion containing 
Dishevelled-associated activator of morphogenesis 2 (DAAM2) and kinesin family member 6 
(KIF6) and a 56bp 3q21.1 insertion containing part of family with sequence similarity 162 
member A (FAM162A) (27-29) (Figure 5).  There are two distinguishing clinical features in 
these CGH families.  In the Chinese family, the presence of spina bifida in the proband and 
scoliosis in 4 family members implicates a role for SOX3, which has been linked to neural tube 
defects in man (24,25), chicken (26), Drosophila (30) and zebrafish (31).  In the Mexican 
family with the 6p21.2 and 3q21.1 insertions, several members also had dental anomalies.  The 
disease mechanism in this family was postulated to be a position effect on fibroblast growth 
factor 13 (FGF13), located ~1.2Mb proximal to the insertion site, and decreased expression of 
FGF13, which is found in developing hair follicles, dental mesenchyme and in developing 
tooth buds, was detected in patient keratinocytes (27).  By contrast, a patient with XX male sex 
reversal was found to have a 4bp deletion at the same locus on Xq27.1 and a ~774kb 1q25.2-
Page 17 of 40 Accepted Manuscript published as EC-19-0478.R1. Accepted for publication: 20-Jan-2020
Copyright © 2019 the authors Downloaded from Bioscientifica.com at 01/31/2020 10:43:12AM
via University of East Anglia
18
25.3 insertion containing 6 complete genes (acyl-CoA binding domain containing 6 (ACBD6), 
xenotropic and polytropic retrovirus receptor 1 (XPR1), unknown gene KIAA1614, syntaxin 6 
(STX6), ovarian adenocarcinoma amplified long non-coding RNA (OVAAL), and microRNA 
3121 (MIR3121)) and two partial genes (LIM homeobox 4 (LHX4) and major 
histocompatibility complex, class-I related (MR1)), that switched on SOX3 expression in 
lymphoblastoid cells from the patient but did not affect FGF13 expression (12) (Figure 5).  
Combined, these studies demonstrate that diverse phenotypes can result from similar sized 
insertions into the same Xq27.1 locus, and that similar phenotypes (e.g. CGH) can result from 
insertions from different autosomes, highlighting the complexity underlying long-range gene 
regulation and the effects of chromosomal rearrangements in disease.  Indeed, Hi-C chromatin 
interaction analyses have revealed that the alterations of genomic repressors or enhancers can 
affect long-range gene expression, and thus it is feasible that these deletion-insertions of 
Xq27.1 may affect genes that are nearby SOX3, but which exert their effects on different 
distant genes.  For example, MIR505 located downstream of SOX3 (Figure 1 and 5) encodes a 
microRNA that inhibits: neural tube formation by targeting fibroblast growth factor 18 
(FGF18) located on chromosome 5q35.1 (32); and cell growth and endothelial migration by 
targeting mitogen-activated protein kinase kinase kinase 3 (MAP3K3) through the AKT-NF-
𝛋B pathway whose genes are located on chromosomes 17q23.3 (MAP3K3), 14q32.33 (AKT 
serine/threonine kinase 1 (AKT)), 10q24.31 (component of inhibitor of nuclear factor kappa B 
kinase complex (IKK1)), 8p11.21 (inhibitor of nuclear factor kappa B kinase subunit beta 
(IKK2)), 4q24 (nuclear factor kappa b subunit 1 (NFKB1)), and 11q13.1 (RELA proto-
oncogene, NF-KB subunit (RELA)) (33).  Thus, altered expression of MIR505 could be 
involved in the occurrence of spina bifida in the proband from the Chinese family with CGH 
that is associated with a deletion of Xq27.1 and insertion of 5q35.3 (29), although it also 
remains possible that it is the deletion-insertion associated disruption of SOX3 itself that is 
responsible for spina bifida, as SOX3 dysfunction has been reported to be linked to neural tube 
Page 18 of 40Accepted Manuscript published as EC-19-0478.R1. Accepted for publication: 20-Jan-2020
Copyright © 2019 the authors Downloaded from Bioscientifica.com at 01/31/2020 10:43:12AM
via University of East Anglia
19
defects in human (24,25).  Different mechanisms are likely to be involved in the phenotypes of 
the other CGH families with insertions of 4q31.22-31.23 and 6p21.2 (27,28), and the XX male 
sex reversal patient, with insertion of 1q25.2-25.3, who did not have neural tube defects (12).  
Thus, it seems that different types of insertions in the same locus can affect expression in other 
genes and thereby result in different phenotypes.  Plasma biochemistry has not been reported in 
CGH or XX male sex reversal, and thus any co-occurrence of HPT and associated 
hypocalcaemia in these patients remains unknown, although such occurrence of HPT in these 
patients would seem unlikely as hypocalcaemic seizures are likely to have been recognized and 
also as XLHPT patients do not have hypertrichosis or XX male sex reversal.
In the two XLHPT families, the two deletions within Xq27.1 are of different sizes but do 
overlap, whilst the two insertions which both originate from 2p25.3 do not overlap, and both 
deletion-insertions lead to a net gain of DNA of differing amounts (~315kb and ~46kb), 
resulting in the same phenotype.  This comparison may help to elucidate the mechanism(s) by 
which the deletion-insertion alters SOX3 expression (Figure 1B).  First, this may be due to loss 
of an enhancer or repressor from the shared missing segment of the X chromosome.  This is 
possible because there is overlap such that the 1.5kb deletion in the IL family is contained 
within the 25kb deletion from the MO family, but unlikely because the small 1.5kb region does 
not contain any ultraconserved sequences.  Second, this may be due to gain of an enhancer or 
repressor within the inserted DNA.  This is possible because most of the inserted DNA is non-
coding, but unlikely because the two inserted regions in the two families do not overlap, and 
there is a low probability that two different insertions would both result in the same subtle 
effect on timing of SOX3 expression in the developing parathyroid glands, as is postulated in 
these two families.  Third, the deletion-insertion may move an enhancer or repressor away 
from SOX3.  This is possible because both deletion-insertions cause net gain of DNA.  One 
such regulatory element, which has been shown to be a likely enhancer of gene expression in 
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zebrafish, is uc482 (16), although uc482 has not been shown directly to affect SOX3 expression 
and our studies reveal that mice lacking uc482 do not develop HPT (Figure 4 and Table 2).  
However, there are also 4 other ultraconserved elements in the region between SOX3 and 
uc482, all of which would also be affected by the interstitial deletion-insertions (16), so a 
combinatorial loss of these elements may be required to alter SOX3 expression and cause HPT. 
Finally, the deletion-insertion may disrupt a topological associated domain (TAD), which 
represents a fundamental three-dimensional evolutionarily conserved genomic structural unit 
that directs regulatory elements to their promoters and insulates them from other genes (34,35).  
Examination for the locations of TAD boundaries on the X chromosome in human non-
parathyroid cell types using Hi-C chromatin interaction data  did not identify TAD boundaries 
between the SOX3 and ATP11C genes, with the nearest TAD boundary being located 
approximately 135kb upstream of SOX3 (36).  It is therefore unlikely that the deletion/insertion 
involving chromosomes Xq27.1 and 2p25.3 altered an existing TAD boundary on the X 
chromosome, although the possibility that the inserted chromatin may have resulted in the 
generation of a new TAD boundary to alter SOX3 expression cannot be excluded.
SOX3 expression was not altered by the Xq27.1/2p25.3 deletion-insertion in EBV-
lymphoblastoid cells from our XLHPT patients (Figure 2), and this may or may not reflect the 
situation in developing parathyroid cells.  However, absence of Sox3 expression that would 
occur in parathyroids of mutant mice with deletion of Sox3 did not result in hypocalcemia or 
HPT in Sox3-/Y mice (Figure 3 and Table 1).  Thus, this result indicates that complete loss of 
Sox3 expression is unlikely to cause HPT, and that XLHPT is likely to be due to a more 
complex mechanism.
Nevertheless, a role for SOX3 in parathyroid development is highly likely as Sox3 expression 
has been detected in developing mouse parathyroid glands between E10.5 and E15.5 (8).  
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However, the absence of any decrease in parathyroid size or development of HPT in mice 
lacking Sox3, even when challenged with a low calcium diet lacking vitamin D, indicates that 
loss of Sox3 alone is not sufficient to cause HPT and that other SOX family transcription 
factors may compensate for loss of SOX3.  Indeed, SOX proteins, which are arranged into 
groups designated A-H, compensate for each other within the same group.  For example, two 
members of the SOXF group, SOX17 and SOX18, compensate for each other in developing 
vascular endothelial cells (37).  SOX3 is a member of the SOXB1 group, which also includes 
SOX1 and SOX2, and all three members share significant protein sequence homology, which 
is at its greatest (~95%) within the high mobility group (HMG) DNA binding domain (38).  
Furthermore, these SOXB1 members have overlapping expression patterns in the central 
nervous system (CNS) (38), and despite expression of Sox3 throughout the developing CNS, 
Sox3 null mice develop specific defects only in the hippocampus, corpus callosum and 
hypothalamus, and it is therefore postulated that partial compensation by SOX1 and/or SOX2 
may prevent a more severe neurological phenotype in Sox3 null mice (19,39). Indeed, 
redundancy between SOX2 and SOX3 has been shown for morphogenesis of the second 
pharyngeal arch during development in mice (39). The related SOXB1 factor, SOX19B, also 
acts redundantly with SOX3 in restricting WNT signalling to the organiser during CNS 
development and dorsoventral patterning (40).
The absence of HPT in Sox3-/Y and Sox3+/- mice indicates that loss of Sox3 expression is not 
the underlying mechanism in XLHPT.  Altered expression of Sox3 in three other ways could 
potentially be considered as possible mechanisms for XLHPT.  First, the deletion-insertions 
may result in Sox3 overexpression.  However, this seems unlikely, as patients with SOX3 
duplications have been reported to have hypopituitarism, mental retardation, and XX male sex 
reversal, which are not features of XLHPT (24,41,42).  The other two possible mechanisms are 
that Sox3 could either be expressed inappropriately early in the developing pharyngeal 
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pouches, or that there might be inappropriate continued expression after the window in which 
Sox3 would normally be expressed.  Sox3 expression in the mouse is detected in developing 
parathyroid glands at E10.5, E13.5, and E15.5, but not at E18.5, indicating that the timing of 
Sox3 expression is likely to be important, as has been shown for other SOX proteins during 
organogenesis.  For example, SRY expression in somatic cells of the male genital ridge has a 
critical expression window of only ~6 hours, during which its expression must reach a certain 
threshold level to trigger Sertoli cell differentiation (43).  Consistent with this hypothesis, we 
could not demonstrate altered SOX3 expression in lymphoblastoid cells from XLHPT patients, 
which might not be representative of SOX3 time and/or tissue specific expression, as for 
example in the parathyroid glands.  Investigation of a temporospatial effect on SOX3 
expression in developing parathyroid glands is not possible in XLHPT patients, and will 
require a mouse model engineered to harbour the appropriate chromosomal rearrangements. 
The lower plasma urea and creatinine concentrations in the wild-type and mutant Sox3 mice, 
which are on a MF1 outbred background when on the low calcium and vitamin D diet (low 
diet) is interesting and likely to be a strain specific response to this dietary challenge.  Thus, the 
plasma urea and creatinine concentrations did not decrease in response to the challenge with 
the low calcium and vitamin D diet, in the wild-type and mutant uc482 mice (Figure 4E-F), 
which are on a C57Bl/6 background, and in previously reported wild-type and mutant Gata3 
mice, which were on a FVB/N background, (21).  The findings of a decreased plasma urea and 
creatinine concentrations in both wild-type and mutant Sox3 mice, but not in wild-type or 
mutant uc482 and Gata3 mice, indicate that these decreased plasma concentrations are not 
mutant dependent, but instead are strain-specific and may involve modifier genes that influence 
urea and creatinine metabolism.  In addition, the observed changes in creatinine metabolism 
due to low vitamin D in the MF1 strain (Figure 3) are similar to that reported in healthy 
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populations (without chronic kidney diseases) from Taiwan and Spain, in whom low dietary 
vitamin D was found to correlate with low plasma creatinine concentrations (44,45).
In conclusion, XLHPT does not result from absence of expression of SOX3 or absence of the 
regulatory element uc482. Instead, the interstitial deletion-insertions likely have other effects 
on the temporospatial expression of SOX3 in the developing parathyroid glands.  
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FIGURE LEGENDS
Figure 1. Chromosomal rearrangements associated with XLHPT.  (A) Unrelated families 
from Missouri (MO) and Illinois (IL), USA, have interstitial deletion-insertions involving 
chromosome Xq27.1 and chromosome 2p25.3.  In the MO kindred, a 25kb Xq27.1 deletion is 
replaced by a ~340kb inverted insertion containing exons 2-16 of syntrophin gamma 2 
(SNTG2).  In the IL family, a 1.5kb Xq27.1 deletion is replaced by a 47kb 2p25.3 insertion that 
does not contain any coding DNA.  These deletion-insertions occur downstream of SRY-box 3 
(SOX3) and upstream of adenosine triphosphatase 11C (ATP11C) and the ultraconserved 
element uc482.  uc482 is a genome region conserved from human through mouse (Mus), rat 
(Rattus), chicken (Gallus), frog (Xenopus), and puffer fish (Takifugu) to zebrafish (Danio) 
(plotted using Vista Browser).  MIR505 (chromosomal location 139,924,148-139,924,231 
(GRCh38/hg38)) is located within the first intron in two of the nine ATP11C (chromosomal 
location 139,726,346-139,945,276 (GRCh38/hg38)) transcripts and upstream of the remaining 
seven transcripts, five of which are protein-coding. (B) Three possible mechanisms by which 
the XLHPT deletion-insertions may alter SOX3 expression are: 1) loss of an enhancer or 
repressor (represented by box 1) from Xq27.1; 2) gain of an enhancer or repressor (represented 
by box 2) from 2p25.3; or 3) movement of an enhancer or repressor (represented by box 3) 
away from SOX3, as the insertion is larger than the deletion.
Figure 2.  SOX3, SNTG2, and ATP11C expression in XLHPT family members.  (A) 
Confirmation of the Xq27.1-2p25.3 deletion-insertion by PCR using primers spanning the 
telomeric breakpoint (Figure 1) in 4 carrier females (circles with dots), and 3 affected males 
(filled squares) from the MO kindred.  Three unaffected related males (open squares) in whom 
the Xq27.1-2p25.3 insert is not present are also shown.  The PCR primers were designed to 
yield a wild-type (WT) product of 237bp in size, and a mutant (M) product of 321bp in size.  S 
= size marker.  (B) Quantitative reverse transcriptase (qRT)-PCR analyses of SOX3, ATP11C, 
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and SNTG2 expression using mRNA obtained from EBV-lymphoblastoids from unaffected 
males (unaff) (n=3), affected males (aff) (n=3) and carrier females (carriers) (n=4), (n=4 
replicates for each individual).  Data are displayed as mean+SD relative to expression in 
unaffected males.
Figure 3. Plasma biochemistry and parathyroid gland sizes in wild-type and mutant Sox3 
mice consuming either control or low calcium and vitamin D diets.  (A) Genotyping of 
wild-type (Sox3+/Y) and hemizygous (Sox3-/Y) male, and wild-type (Sox3+/+) and heterozygous 
(Sox3+/-) female mice.  S: size marker; B: blank; WT: wild-type band; mut: mutant band. (B) 
plasma corrected calcium; (C) plasma PTH; (D) plasma alkaline phosphatase (ALP) activity; 
(E) plasma urea; (F) plasma creatinine; (G) parathyroid gland area.  Wild-type males (+/Y) and 
mutant males (-/Y) are shown by the dark grey and light grey solid bars, respectively.  Wild-
type females (+/+) and mutant carrier females (+/-) are shown by the dark grey and light grey 
hatched bars, respectively.  Data are displayed as mean±SD.  * p < 0.05; ** p < 0.01; $ p < 
0.001; $$ p < 0.0001 for mice on the low calcium and vitamin D (low Ca2+ and vit D) diet 
compared to mice of the same genotype on the normal diet.  (H) Representative histological 
images used for quantification of parathyroid gland area.  Pt: parathyroid; Th: thyroid; SM: 
strap muscle. Scale bars = 200µm.
Figure 4.  Plasma biochemistry and parathyroid gland sizes in wild-type and mutant 
uc482 mice consuming either control or low calcium and vitamin D diets.  (A) Genotyping 
of wild-type (uc482+/Y) and hemizygous (uc482-/Y) male, and wild-type (uc482+/+) and 
heterozygous (uc482+/-) female mice. S: size marker; B: blank; WT: wild-type band; mut: 
mutant band.  (B) plasma corrected calcium; (C) plasma PTH; (D) plasma alkaline phosphatase 
(ALP) activity; (E) plasma urea; (F) plasma creatinine; (G) parathyroid gland area.  Wild-type 
males (+/Y) and mutant males (-/Y) are shown by the dark grey and light grey solid bars, 
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respectively.  Wild-type females (+/+) and mutant carrier females (+/-) are shown by the dark 
grey and light grey hatched bars, respectively.  Data are presented as mean±SD.  * p < 0.05; ** 
p < 0.01; $ p < 0.001; $$ p < 0.0001 for mice on the low calcium and vitamin D (low Ca2+ and 
vit D) diet compared to mice of the same genotype on the normal diet. (H) Representative 
histological images used for quantification of parathyroid gland area.  Pt: parathyroid; Th: 
thyroid; SM: strap muscle. Scale bars = 200µm.
Figure 5. Chromosomal rearrangements associated with XX sex reversal and 
hypertrichosis.  A patient with XX sex reversal was found to have an interstitial deletion-
insertion involving chromosome Xq27.1 and chromosome 1q25.3 (11).  One family from 
China and two unrelated families from Mexico with hypertrichosis have been reported to have 
interstitial deletion-insertions involving chromosome Xq27.1 and chromosomes 5q35.3, 4q31, 
and 6p21.2, respectively (23-25).  Dotted lines denote the location of the XLHPT interstitial 
deletion-insertions. 
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Table 1. Plasma biochemistry in 6 and 28 week old wild-type and mutant Sox3 mice 
consuming the control diet.
Males FemalesGenotype:
Sox3+/Y Sox3-/Y
 
Sox3+/+ Sox3+/-
Age: 6 weeks (n=19-22) (n=14-18) (n=23-25) (n=12-15)
Body weight (g) 11.85±3.49 11.74±3.70 12.05±2.30 12.12±2.71
Corr. Ca (mmol/l) 3.08±0.11 3.05±0.15 3.02±0.08 3.06±0.10
PTH (pmol/l) 11.8±7.6 12.8±10.4 15.3±11.8 9.9±10.6
Phosphate (mmol/l) 4.24±0.76 4.10±0.68 4.07±0.62 3.88±0.83
ALP (U/l) 258.7±47.2 270.2±49.4 296.5±58.4 282.4±48.4
Urea (mmol/l) 7.85±1.24 7.83±0.87 6.90±1.13 7.10±0.74
Creatinine (µmol/l) 17.3±0.8 16.8±1.3 17.7±0.9 17.7±1.6
Albumin (g/l) 30.5±1.7 31.6±2.7 31.7±2.0 32.3±1.7
Age: 28 weeks (n=10-14) (n=15-19) (n=8-12) (n=14-18)
Body weight (g) 47.51±6.81 50.17±9.23 32.16±1.66 40.93±8.92
Corr. Ca (mmol/l) 2.83±0.19 2.79±0.12 2.65±0.12 2.73±0.11
PTH (pmol/l) 41.8±31.4 35.9±34.1 35.6±23.8 24.8±19.1
Phosphate (mmol/l) 3.33±0.49 3.26±0.54 2.97±0.21 3.06±0.64
ALP (U/l) 81±15 74±12 98±24 90±24
Urea (mmol/l) 8.3±1.12 8.2±0.82 7.2±1.4 8.1±1.2
Creatinine (µmol/l) 15.9±0.9 16.2±1.5 16.1±1.7 17.3±1.5
Albumin (g/l) 29.5±2.2 30.7±0.8 32.2±1.5 31.9±1.9
Corr. Ca: corrected calcium; PTH: parathyroid hormone; ALP: alkaline phosphatase. 
Mean±SD values are shown.  Wild-type males (Sox3+/Y), mutant males (Sox3-/Y), wild-type 
females (Sox3+/+), and mutant carrier females (Sox3+/-). There were no significant differences 
between knock-out and wild-type littermates at the same age.
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Table 2.  Plasma biochemistry in 8 and 28 week old wild-type and mutant uc482 mice 
consuming the control diet.
Males FemalesGenotype:
uc482+/Y uc482-/Y uc482+/+ uc482+/-
Age: 8 weeks (n=17-25) (n=20-25) (n=9-15) (n=19-44)
Body weight (g) 21.32±2.53 21.62±1.49 17.51±1.25 17.20±1.51
Corr. Ca (mmol/l) 2.95±0.08 2.98±0.10 2.80±0.07 2.84±0.12
PTH (pmol/l) 12.9±9.3 12.1±9.0 11.1±10.4 23.5±24.3
Phosphate (mmol/l) 4.10±0.70 4.17±0.39 4.01±0.54 3.95±0.52
ALP (U/l) 280.7±53.9 279.8±36.8 286.8±41.1 293.8±40.1
Urea (mmol/l) 6.29±0.80 6.16±0.79 6.63±1.04 6.29±1.42
Creatinine (µmol/l) 28.88±2.23 28.63±2.20 28.43±1.55 29.05±2.38
Albumin (g/l) 29.8±1.5 29.0±1.3 32.0±1.9 31.7±1.5
Age: 28 weeks (n=8-14) (n=10-16) (n=11-15) (n=8-12)
Body weight (g) 37.13±4.94 37.79±5.28 27.07±4.93 26.14±4.28
Corr. Ca (mmol/l) 2.76±0.08 2.83±0.13 2.70±0.05 2.72±0.12
PTH (pmol/l) 19.9±16.7 26.7±15.3 18.4±20.2 13.6±12.0
Phosphate (mmol/l) 3.55±0.55 3.71±0.66 3.20±0.54 3.42±0.51
ALP (U/l) 69.7±7.5 71.0±7.0 79.7±8.5 85.3±18.8
Urea (mmol/l) 10.04±1.04 9.23±1.21 8.46±0.83 8.73±1.18
Creatinine (µmol/l) 33.8±2.2 35.3±2.2 33.4±1.7 34.3±3.0
Albumin (g/l) 30.5±1.3 31.1±1.3 31.5±1.8 31.8±1.6
Corr. Ca: corrected calcium; PTH: parathyroid hormone; ALP: alkaline phosphatase.  
Mean±SD values are shown. Wild-type males (uc482+/Y), mutant males (uc482-/Y), wild-type 
females (uc482+/+) and mutant carrier females (uc482+/-). There were no significant differences 
between knock-out and wild-type littermates at the same age.
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